Credit Suisse’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $57.3M | Sell |
321,946
-152,538
| -32% | -$27.1M | 0.05% | 333 |
|
|
2023
Q4 | $58.9M | Buy |
474,484
+240,863
| +103% | +$29.9M | 0.06% | 339 |
|
|
2023
Q3 | $27.1M | Sell |
233,621
-233,567
| -50% | -$27.1M | 0.03% | 558 |
|
|
2023
Q2 | $54.8M | Sell |
467,188
-165,636
| -26% | -$19.4M | 0.05% | 370 |
|
|
2023
Q1 | $50.7M | Sell |
632,824
-50,056
| -7% | -$4.01M | 0.05% | 389 |
|
|
2022
Q4 | $54.1M | Buy |
682,880
+4,410
| +0.6% | +$349K | 0.06% | 355 |
|
|
2022
Q3 | $47.3M | Sell |
678,470
-24,433
| -3% | -$1.7M | 0.05% | 382 |
|
|
2022
Q2 | $46.2M | Sell |
702,903
-54,956
| -7% | -$3.61M | 0.05% | 406 |
|
|
2022
Q1 | $50.4M | Buy |
757,859
+4,179
| +0.6% | +$278K | 0.04% | 434 |
|
|
2021
Q4 | $52.7M | Sell |
753,680
-18,274
| -2% | -$1.28M | 0.03% | 440 |
|
|
2021
Q3 | $40.3M | Buy |
771,954
+5,629
| +0.7% | +$294K | 0.02% | 544 |
|
|
2021
Q2 | $52.1M | Sell |
766,325
-13,075
| -2% | -$889K | 0.03% | 485 |
|
|
2021
Q1 | $60M | Buy |
779,400
+3,872
| +0.5% | +$298K | 0.03% | 460 |
|
|
2020
Q4 | $46.5M | Buy |
775,528
+1,274
| +0.2% | +$76.4K | 0.02% | 532 |
|
|
2020
Q3 | $33.3M | Buy |
774,254
+91,710
| +13% | +$3.95M | 0.02% | 566 |
|
|
2020
Q2 | $28.3M | Buy |
682,544
+102,108
| +18% | +$4.23M | 0.02% | 603 |
|
|
2020
Q1 | $25.1M | Buy |
580,436
+299,818
| +107% | +$13M | 0.02% | 572 |
|
|
2019
Q4 | $15.5M | Buy |
280,618
+212,981
| +315% | +$11.8M | 0.01% | 885 |
|
|
2019
Q3 | $2.35M | Sell |
67,637
-1,575
| -2% | -$54.7K | ﹤0.01% | 1826 |
|
|
2019
Q2 | $2.79M | Buy |
+69,212
| New | +$2.79M | ﹤0.01% | 1719 |
|